Balefire, LLC

Position in EXEL — Exelixis, Inc.

CIK 1750924 DALLAS, TX

Position in EXEL

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$385,930

+$84,757 QoQ

Shares Held

7,093

+1.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#481

of 754 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Balefire, LLC holds $1,269,056 across 5 Biotechnology names. EXEL ranks #1 (30.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	7,093	$385,930
2	LGND	Ligand Pharmaceuticals Inc	1,043	$329,681
3	VRTX	Vertex Pharmaceuticals Inc / Ma	479	$237,933
4	HALO	Halozyme Therapeutics, Inc.	2,936	$229,800
5	ANNX	Annexon, Inc.	15,011	$85,712

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$385,930	7,093	+1.0%	Shares	Sole	2026-07-07
2026-03-31	$301,173	7,022	-5.4%	Shares	Sole	2026-05-07
2025-12-31	$325,350	7,423	+29.4%	Shares	Sole	2026-01-12
2025-09-30	$236,979	5,738	—	Shares	Sole	2025-10-08
No filing history on record for this holder in this stock.